John Oxford

9.0k total citations · 1 hit paper
189 papers, 6.4k citations indexed

About

John Oxford is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, John Oxford has authored 189 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 131 papers in Epidemiology, 48 papers in Infectious Diseases and 39 papers in Molecular Biology. Recurrent topics in John Oxford's work include Influenza Virus Research Studies (111 papers), Respiratory viral infections research (53 papers) and Monoclonal and Polyclonal Antibodies Research (29 papers). John Oxford is often cited by papers focused on Influenza Virus Research Studies (111 papers), Respiratory viral infections research (53 papers) and Monoclonal and Polyclonal Antibodies Research (29 papers). John Oxford collaborates with scholars based in United Kingdom, United States and Italy. John Oxford's co-authors include Rob Lambkin‐Williams, G. C. Schild, Robert G. Webster, C. W. Potter, Anthony Gilbert, Tom Wilkinson, J.C. de Jong, Tao Dong, Robert W. Newman and Cecilia Chui and has published in prestigious journals such as Nature, The Lancet and Nature Medicine.

In The Last Decade

John Oxford

186 papers receiving 6.0k citations

Hit Papers

Preexisting influenza-spe... 2012 2026 2016 2021 2012 250 500 750

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
John Oxford 4.4k 1.8k 1.6k 1.3k 519 189 6.4k
Alan P. Kendal 5.2k 1.2× 1.5k 0.8× 1.0k 0.6× 1.1k 0.9× 672 1.3× 141 6.2k
Edwin D. Kilbourne 5.9k 1.4× 1.5k 0.9× 1.6k 1.0× 1.3k 1.0× 956 1.8× 152 7.5k
Masato Tashiro 6.1k 1.4× 2.8k 1.6× 2.0k 1.3× 1.4k 1.1× 304 0.6× 169 8.3k
Michael W. Shaw 4.3k 1.0× 1.7k 1.0× 1.0k 0.6× 1.2k 0.9× 177 0.3× 100 5.8k
Sang‐Moo Kang 3.9k 0.9× 2.0k 1.1× 3.4k 2.1× 2.5k 1.9× 399 0.8× 238 8.5k
Geert Leroux‐Roels 6.9k 1.6× 2.2k 1.3× 3.0k 1.9× 1.8k 1.4× 912 1.8× 297 11.5k
Andrew Pekosz 3.1k 0.7× 2.9k 1.7× 2.1k 1.3× 2.0k 1.5× 244 0.5× 198 7.7k
Ian Barr 7.1k 1.6× 2.6k 1.5× 1.7k 1.1× 1.8k 1.4× 365 0.7× 288 9.9k
Ted M. Ross 4.4k 1.0× 2.5k 1.4× 3.1k 1.9× 1.8k 1.4× 682 1.3× 269 8.2k
Raphael Dolin 3.7k 0.8× 4.4k 2.5× 1.3k 0.8× 1.1k 0.8× 255 0.5× 152 8.5k

Countries citing papers authored by John Oxford

Since Specialization
Citations

This map shows the geographic impact of John Oxford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Oxford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Oxford more than expected).

Fields of papers citing papers by John Oxford

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Oxford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Oxford. The network helps show where John Oxford may publish in the future.

Co-authorship network of co-authors of John Oxford

This figure shows the co-authorship network connecting the top 25 collaborators of John Oxford. A scholar is included among the top collaborators of John Oxford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Oxford. John Oxford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oxford, John, Paul Kellam, & Leslie Collier. (2016). Human Virology. Oxford University Press eBooks. 4 indexed citations
2.
Oxford, John. (2013). Controlling pandemic flu. ˜The œbiomedical & life sciences collection.. 2013(12). e1003347–e1003347. 2 indexed citations
3.
Oxford, John, et al.. (2011). Furanylidene systems from a tosylic acid-mediated, tandem desilylation-cyclization reaction of silyl ethers of monoalkynylated β-keto carbonyls. Heterocyclic Communications. 17(5-6). 227–231. 2 indexed citations
4.
DeVincenzo, John P., Tom Wilkinson, Akshay Vaishnaw, et al.. (2010). Viral Load Drives Disease in Humans Experimentally Infected with Respiratory Syncytial Virus. American Journal of Respiratory and Critical Care Medicine. 182(10). 1305–1314. 237 indexed citations
5.
Al‐Jabri, Ali A., Rob Lambkin‐Williams, & John Oxford. (2008). Lack of Evidence for Complete Resistance of Peripheral Blood Mononuclear Cells to HIV-1 and HIV-2 Infection. Viral Immunology. 21(1). 83–90. 3 indexed citations
6.
Mett, Vadim, Konstantin Musiychuk, Hong Bi, et al.. (2008). A plant‐produced influenza subunit vaccine protects ferrets against virus challenge. Influenza and Other Respiratory Viruses. 2(1). 33–40. 62 indexed citations
7.
Hull, D., et al.. (2007). Low pH gel intranasal sprays inactivate influenza viruses in vitro and protect ferrets against influenza infection. Respiratory Research. 8(1). 38–38. 22 indexed citations
8.
Elliot, Alex J., David A. Steinhauer, Rod S. Daniels, & John Oxford. (2006). Functional and antigenic analyses of the 1918 influenza virus haemagglutinin using a recombinant vaccinia virus expression system. Virus Research. 122(1-2). 11–19. 6 indexed citations
9.
Lambkin‐Williams, Rob, Patricia Novelli, John Oxford, & Colin Gelder. (2004). Human Genetics and Responses to Influenza Vaccination. PubMed. 4(5). 293–298. 38 indexed citations
10.
Fries, Louis, Rob Lambkin‐Williams, Colin Gelder, et al.. (2004). FluINsure™, an inactivated trivalent influenza vaccine for intranasal administration, is protective in human challenge with A/Panama/2007/99 (H3N2) virus. International Congress Series. 1263. 661–665. 6 indexed citations
11.
Oxford, John, et al.. (2003). Treatment of epidemic and pandemic influenza with neuraminidase and M2 proton channel inhibitors. Clinical Microbiology and Infection. 9(1). 1–14. 210 indexed citations
12.
Oxford, John, et al.. (2003). A new infectious disease challenge: Urbani severe acute respiratory syndrome (SARS) associated coronavirus. Immunology. 109(3). 326–328. 15 indexed citations
13.
Oxford, John, A. Sefton, R Jackson, et al.. (2001). Early herald wave outbreaks of influenza in 1916 prior to the pandemic of 1918. International Congress Series. 1219. 155–161. 6 indexed citations
14.
Collier, Leslie & John Oxford. (2000). Human virology: a text for students of medicine, dentistry, and microbiology.. Oxford University Press eBooks. 9 indexed citations
15.
Oxford, John. (2000). Influenza A pandemics of the 20th century with special reference to 1918: virology, pathology and epidemiology. Reviews in Medical Virology. 10(2). 119–133. 162 indexed citations
16.
Habeshaw, J A, Susan E. Wilson, Elizabeth F. Hounsell, & John Oxford. (1999). How HIV-1 lentivirus causes immune deficiency disease. Medical Hypotheses. 52(1). 59–67. 10 indexed citations
17.
Wilson, Susan E., et al.. (1997). HIV Type 1 Envelope Glycoprotein 120 Carboxy-Terminal Peptide-Induced Human T Cell Lines Selectively Suppress Heterogeneous Proliferative T Cell Responses to Soluble Antigens. AIDS Research and Human Retroviruses. 13(15). 1313–1324. 10 indexed citations
18.
Stein, Christian, et al.. (1994). Sequence analysis of proviral HIV RT amplified directly by a semi‐quantitative technique from AZT treated patients. Journal of Medical Virology. 44(2). 115–121. 7 indexed citations
19.
Oxford, John, et al.. (1993). Challenges and strategies for AIDS vaccine development. Vaccine. 11(6). 612–614. 10 indexed citations
20.
Potter, C. W., Janelle M. Hoskins, & John Oxford. (1969). Immimological relationships of some oncogenic DNA viruses. Archives of Virology. 27(1). 73–86. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026